Tag Archives | JAMA

Whole Genome Sequencing will open up new era of Personalized Medicine

Sally Church on Pharma Strategy Blog discusses two papers and an editorial on Whole Genome Sequencing published in the Journal of the American Medical Association (JAMA) this week. The ability to sequence and screen the entire genetic information of an individual is now within reach.  DNA sequencing costs have decreased over a 100-fold over the […]

Continue Reading

The relationship between HRT and Breast Cancer

Sally Church on Pharma Strategy Blog discusses the issue of to what extent hormone replacement therapy (HRT) is linked to a higher incidence of breast cancer? Recent data published in the Journal of the American Medical Association (JAMA) showed a reduction in breast cancer incidence for those taking conjugate equine estrogens.  This is in sharp […]

Continue Reading